The luminal A subtype also had a higher likelihood of HER2+ DTCs being detected than luminal B/HER2− or luminal B/HER2+ (r = −0.59, p = 0.001), suggesting discordance between DTCs and the primary tumor profile. The gene discussed is ERBB2; the disease is neoplasm.